Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haoxi Health Technology (HAO) Cash & Current Investments (2023 - 2025)

Haoxi Health Technology has reported Cash & Current Investments over the past 3 years, most recently at $8.6 million for Q2 2025.

  • Quarterly results put Cash & Current Investments at $8.6 million for Q2 2025, up 29.49% from a year ago — trailing twelve months through Jun 2025 was $8.6 million (up 29.49% YoY), and the annual figure for FY2025 was $8.6 million, up 29.49%.
  • Cash & Current Investments for Q2 2025 was $8.6 million at Haoxi Health Technology, up from $6.7 million in the prior quarter.
  • Over the last five years, Cash & Current Investments for HAO hit a ceiling of $8.6 million in Q2 2025 and a floor of $1.2 million in Q2 2023.
  • Median Cash & Current Investments over the past 3 years was $6.7 million (2024), compared with a mean of $5.5 million.
  • Biggest five-year swings in Cash & Current Investments: soared 453.17% in 2024 and later rose 29.49% in 2025.
  • Haoxi Health Technology's Cash & Current Investments stood at $1.2 million in 2023, then soared by 453.17% to $6.7 million in 2024, then grew by 29.49% to $8.6 million in 2025.
  • The last three reported values for Cash & Current Investments were $8.6 million (Q2 2025), $6.7 million (Q2 2024), and $1.2 million (Q2 2023) per Business Quant data.